Xenobiotics effect xylene and toluene at the total antioxidative and lipid status;Efekti ksenobiotika ksilena i toluena na ukupni antioksidativni i lipidni status

Jugoslovenska Medicinska Biohemija

Volumn 23, Issue 1, 2004, Pages 65-68

  Knežević, Veroljub ^a,b   Joksović, Dragan ^c   Knežević, Olgica ^b  

^a Health Centre of Kragujevac ^*  (Serbia)

^b Health Centre Kragujevac   (Serbia)

^c UNIVERSITY OF DEFENCE   (Serbia)

Author keywords

Antioxidative status; Lipid status; Toluene; Xylene

Indexed keywords

ANTIOXIDANT; FREE RADICAL; HIGH DENSITY LIPOPROTEIN; HIPPURIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TOLUENE; TRIACYLGLYCEROL; XENOBIOTIC AGENT; XYLENE;

ARTICLE; CELL MEMBRANE; CELL STRUCTURE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; OCCUPATIONAL EXPOSURE; PROTEIN MODIFICATION; TRIACYLGLYCEROL BLOOD LEVEL; URINE LEVEL; WORKER; XENOBIOTIC METABOLISM;

EID: 1842511787     PISSN: 03543447     EISSN: None     Source Type: Journal    
DOI: 10.2298/JMH0401065K     Document Type: Article

References (16)

1. Van Doom R, Bos RP, Brouns RM, Leijdekkers CM, Henerson PT. Effect of toluene and xylene on liver glutathione and their urinary excretion as mercapturic acids in the rat. Arch Toxicol 1980; 43: 293-304.
2. Hass U, Jakobsen BM. Prenatal toxicity of xylene inhalation in the rat: a teratogenicity and postnatal study. Pharmacol Toxicol 1993; 73: 20-23.
3. Angerer J, Schildbach M, Kramer A. S-p-Toluilmercapturic acid in the urine of workers exposed to toluene: a new bomareker for toluene exposure. Arch Toxicol 1998; 72: 119-23.
4. Harman D. Free radical theory of ageing: role of free radicals in the origination and evolution of life ageing and disease processes. Ann NY Acad Sci 1996; 786: 321-36.
5. Cheng S, Pallaud C, Grow MA, Scharf SJ, Erlich HA, Klitz W, et al. A. multloous genotyping assay for cardiovascular disease. Clinic Chem Lab Med 1998; 36: 561-6.
6. Brown MS, Goldstein JL. A receptor/mediated pathway for cholesterol homeostasis. Science 1986; 232: 34-47.
7. Prpić D, Majić C. Toksikološko-hemijske analize. Medicinska knjiga. Zagreb - Beograd, 1985, 273.
8. Jevtović I. Medicinska statistika. Medicinska knjiga. Kragujevac, 1996, 113.
9. Steinberg D, Parhasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoproteins that increases its atherogenicity. N Engel J Med 1989; 320: 915-24.
10. Gerity RG. Role of the monocyte in atherogenesis. 1. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981; 103: 181-90.
11. Geer JC, Haust MD. Smooth muscle cells in atherosclerosis. Monographs on atherosclerosis 1972; vol 12, Karger, Basel.
12. Mugge A, Brandes RP, Boger RH, Dwenger A, Bode-Boger S, Kienke S, Frolich JC, Lichtlen PR. Vascular release of superoxide radicals is enhance in hypercholeserolemic rabbits. J Cardiovasc Pharmacol 1994; 24: 994-8.
13. Frostegard J, Wu R, Giscombe R, Holm G, Lefvert AK, Nilsson J. Induction od T-cell activation by oxidized low densiti lipoprotein. Arterioscler Thromb 1992; 12: 461-7.
14. Lehr HA, Becker M, Marklund SL, Hubner C, Arfors KE, Kohlschutter A, Messmer K. Superoxide/dependent stimulation of leukocyte adhesion by oxidatively modified LDL in vivo. Arterioscler Throm 1992; 12: 824-9.
15. Jacob RA. The integrated antioxidant system Nutr Res 1995; 15: 755-66.
16. Rama SV, Kumar S. Antioxidative enzyme in the liver of rats after exposure to xylene, toluene and methyl alcohol separately and in combination. Physiol Chem Phys Med NMR 27 (1) 1995; 25-29.